Suven Life Sciences bags patent for neuro-degenerative drug
The patents from Europe, Japan and New Zealand are valid till 2034
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Piramal arm DRG acquires US firm Context Matters
New York-based Context Matters is in health economics data service, catering to the life sciences industry
PerkinElmer India opens centre of excellence at IISER Pune
The centre will help educate the region’s current and future scientists on high-throughput analyses in life sciences
Johnson & Johnson in partnership with CSIR-IMTECH
To develop innovative new tuberculosis treatments
DoP observes Swachhta Pakhwada
The department has involved various pharma and medical devices associations and their manufactures, traders, retailers and…
Biocon withdraws application for EU approval of two drugs
EU drugs regulator sought re-inspection of their production facility
Zydus Cadila receives US FDA approval for blood pressure drug
The drug will be manufactured at the groups formulations manufacturing facility at pharma SEZ in Ahmedabad
Suven’s revenue declines by 21 per cent
PAT was registered at Rs 295 million against Rs 403 million
Zydus settles patent case over Aptalis’ drug Canasa
Canasa is indicated to treat mildly to moderately active ulcerative colitis
Natco gets US FDA nod to market renal disease drug
The product, as the first generic, will be launched shortly in the US market